ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Pneumothorax Therapy: Manual Aspiration Versus Conventional Chest Tube Drainage (pneumothorax)

This study is currently recruiting participants.
Verified by Isala Klinieken, November 2007

Sponsored by: Isala Klinieken
Information provided by: Isala Klinieken
ClinicalTrials.gov Identifier: NCT00556335
  Purpose

The purpose of this study is to evaluate the efficacy of manual aspiration in comparison to conventional chest tube drainage in pneumothorax therapy:

  1. whether manual aspiration will shorten hospital admission.
  2. whether the lung will expand by means of clinical and radiological findings.

Condition Intervention
Pneumothorax
Procedure: manual aspiration
Procedure: conventional drainage

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Official Title:   A Prospective, Randomised Trial in Pneumothorax Therapy: Manual Aspiration Versus Conventional Chest Tube Drainage

Further study details as provided by Isala Klinieken:

Primary Outcome Measures:
  • The duration of length of stay of each technique [ Time Frame: 1 year ]

Secondary Outcome Measures:
  • The success rate of each technique [ Time Frame: 1 year ]

Estimated Enrollment:   114
Study Start Date:   April 2007
Estimated Study Completion Date:   April 2009

Arms Assigned Interventions
A: Experimental
manual aspiration
Procedure: manual aspiration
air aspiration
B: Active Comparator
conventional drainage
Procedure: conventional drainage
drainage, pneumocath

Show detailed description  Show Detailed Description

  Eligibility
Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Criteria

Inclusion Criteria:

  • patients with a first episode of a symptomatic pneumothorax admitted to the ER of the hospital (spontaneous or traumatic) or
  • patients with an asymptomatic pneumothorax with a size of ≥ 20 % as estimated by Light's formula
  • age ≥ 18 and < 85 years
  • smoking is tolerated

Exclusion Criteria:

  • recurrent pneumothorax
  • lung fibrosis
  • patients with (lung) cancer
  • pregnant women
  • comorbidity limiting decision making (psychiatric disease, alcohol or drug abuse)
  • prior randomisation
  • Marfan syndrome
  • COPD patients
  • tension pneumothorax
  • multi-trauma patients
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00556335

Contacts
Contact: J.W. van den Berg, PhD     +31 38 4242000 ext 4474     j.w.k.van.den.berg@isala.nl    

Locations
Netherlands
Isala Klinieken     Recruiting
      Zwolle, Netherlands, 8011 JW
      Contact: J.W. van den Berg, Dr.     038-4242000 ext 4474        
      Principal Investigator: L.N. Boom            

Sponsors and Collaborators
Isala Klinieken

Investigators
Study Director:     J.W. van den Berg, Dr.     Isala Klinieken department of pulmonology    
  More Information


Publications:

Study ID Numbers:   NL13097.075.06
First Received:   November 9, 2007
Last Updated:   November 9, 2007
ClinicalTrials.gov Identifier:   NCT00556335
Health Authority:   Netherlands: The Central Committee on Research Involving Human Subjects (CCMO)

Keywords provided by Isala Klinieken:
manual aspiration  
conventional  
length of stay  

Study placed in the following topic categories:
Respiratory Tract Diseases
Pleural Diseases
Pneumothorax

ClinicalTrials.gov processed this record on September 22, 2008




Links to all studies - primarily for crawlers